These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 12629078)

  • 1. Age-related changes in cortical bone content of insulin-like growth factor binding protein (IGFBP)-3, IGFBP-5, osteoprotegerin, and calcium in postmenopausal osteoporosis: a cross-sectional study.
    Ueland T; Brixen K; Mosekilde L; Mosekilde L; Flyvbjerg A; Bollerslev J
    J Clin Endocrinol Metab; 2003 Mar; 88(3):1014-8. PubMed ID: 12629078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum levels of insulin-like growth factor (IGF); IGF-binding proteins-3, -4, and -5; and their relationships to bone mineral density and the risk of vertebral fractures in postmenopausal women.
    Yamaguchi T; Kanatani M; Yamauchi M; Kaji H; Sugishita T; Baylink DJ; Mohan S; Chihara K; Sugimoto T
    Calcif Tissue Int; 2006 Jan; 78(1):18-24. PubMed ID: 16397738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A potentially deleterious role of IGFBP-2 on bone density in aging men and women.
    Amin S; Riggs BL; Atkinson EJ; Oberg AL; Melton LJ; Khosla S
    J Bone Miner Res; 2004 Jul; 19(7):1075-83. PubMed ID: 15176989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of 12 months of GH treatment on cortical and trabecular bone content of IGFs and OPG in adults with acquired GH deficiency: a double-blind, randomized, placebo-controlled study.
    Ueland T; Bollerslev J; Flyvbjerg A; Hansen TB; Vahl N; Mosekilde L
    J Clin Endocrinol Metab; 2002 Jun; 87(6):2760-3. PubMed ID: 12050246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in the serum growth factors and osteoprotegerin after bone marrow transplantation: impact on bone and mineral metabolism.
    Baek KH; Lee WY; Oh KW; Kim HS; Han JH; Kang MI; Cha BY; Lee KW; Son HY; Kang SK; Kim CC
    J Clin Endocrinol Metab; 2004 Mar; 89(3):1246-54. PubMed ID: 15001618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of sex hormone replacement on the insulin-like growth factor system and bone mineral: a cross-sectional and longitudinal study in 595 perimenopausal women participating in the Danish Osteoporosis Prevention Study.
    Vestergaard P; Hermann AP; Orskov H; Mosekilde L
    J Clin Endocrinol Metab; 1999 Jul; 84(7):2286-90. PubMed ID: 10404791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum levels of insulin-like growth factor binding proteins (IGFBP)-4 and -5 correlate with bone mineral density in growth hormone (GH)-deficient adults and increase with GH replacement therapy.
    Thorén M; Hilding A; Brismar T; Magnusson P; Degerblad M; Larsson L; Sääf M; Baylink DJ; Mohan S
    J Bone Miner Res; 1998 May; 13(5):891-9. PubMed ID: 9610754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum osteoprotegerin levels in patients after liver transplantation and correlation to bone turnover, bone mineral density and fracture status.
    Fahrleitner A; Prenner G; Kniepeiss D; Iberer F; Tscheliessnigg KH; Piswanger-Sölkner C; Obermayer-Pietsch B; Leb G; Dobnig H
    Wien Klin Wochenschr; 2002 Aug; 114(15-16):717-24. PubMed ID: 12602117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum levels of insulin-like growth factor (IGF) I, IGF-binding protein (IGFBP)-2, and IGFBP-3 in osteoporotic patients with and without spinal fractures.
    Sugimoto T; Nishiyama K; Kuribayashi F; Chihara K
    J Bone Miner Res; 1997 Aug; 12(8):1272-9. PubMed ID: 9258758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased cortical bone content of insulin-like growth factors in acromegalic patients.
    Ueland T; Bollerslev J; Hansen TB; Ebbesen EN; Mosekilde L; Brixen K; Flyvbjerg A; Djøseland O
    J Clin Endocrinol Metab; 1999 Jan; 84(1):123-7. PubMed ID: 9920071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of osteoprotegerin gene polymorphism on bone mass in postmenopausal women].
    Cheng Q; Zhu HM; Miao YX; Zhu XY; Chen XP; Zhang XM
    Zhonghua Yi Xue Za Zhi; 2004 Feb; 84(4):274-7. PubMed ID: 15059506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Down-regulation of the serum stimulatory components of the insulin-like growth factor (IGF) system (IGF-I, IGF-II, IGF binding protein [BP]-3, and IGFBP-5) in age-related (type II) femoral neck osteoporosis.
    Boonen S; Mohan S; Dequeker J; Aerssens J; Vanderschueren D; Verbeke G; Broos P; Bouillon R; Baylink DJ
    J Bone Miner Res; 1999 Dec; 14(12):2150-8. PubMed ID: 10620075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone mineral density in femoral neck is positively correlated to circulating insulin-like growth factor (IGF)-I and IGF-binding protein (IGFBP)-3 in Swedish men.
    Gillberg P; Olofsson H; Mallmin H; Blum WF; Ljunghall S; Nilsson AG
    Calcif Tissue Int; 2002 Jan; 70(1):22-9. PubMed ID: 11907704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of C161-->T polymorphisms in exon 6 of peroxisome proliferator-activated receptor-gamma gene on bone mineral metabolism and serum osteoprotegerin levels in healthy middle-aged women.
    Rhee EJ; Oh KW; Lee WY; Kim SY; Oh ES; Baek KH; Kang MI; Kim SW
    Am J Obstet Gynecol; 2005 Apr; 192(4):1087-93. PubMed ID: 15846185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High serum IGFBP-2 is predictive of increased bone turnover in aging men and women.
    Amin S; Riggs BL; Melton LJ; Achenbach SJ; Atkinson EJ; Khosla S
    J Bone Miner Res; 2007 Jun; 22(6):799-807. PubMed ID: 17352648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The changes in circulating osteoprotegerin after hormone therapy in postmenopausal women and their relationship with oestrogen responsiveness on bone.
    Han KO; Choi JT; Choi HA; Moon IG; Yim CH; Park WK; Yoon HK; Han IK
    Clin Endocrinol (Oxf); 2005 Mar; 62(3):349-53. PubMed ID: 15730418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating estradiol and osteoprotegerin as determinants of bone turnover and bone density in postmenopausal women.
    Rogers A; Saleh G; Hannon RA; Greenfield D; Eastell R
    J Clin Endocrinol Metab; 2002 Oct; 87(10):4470-5. PubMed ID: 12364420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunological characterization of circulating osteoprotegerin/osteoclastogenesis inhibitory factor: increased serum concentrations in postmenopausal women with osteoporosis.
    Yano K; Tsuda E; Washida N; Kobayashi F; Goto M; Harada A; Ikeda K; Higashio K; Yamada Y
    J Bone Miner Res; 1999 Apr; 14(4):518-27. PubMed ID: 10234572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determinants of bone mineral density and spinal fracture risk in postmenopausal Japanese women.
    Nakaoka D; Sugimoto T; Kaji H; Kanzawa M; Yano S; Yamauchi M; Sugishita T; Chihara K
    Osteoporos Int; 2001; 12(7):548-54. PubMed ID: 11527051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone mineral density and serum levels of soluble tumor necrosis factors, estradiol, and osteoprotegerin in postmenopausal women with cirrhosis after viral hepatitis.
    González-Calvin JL; Mundi JL; Casado-Caballero FJ; Abadia AC; Martin-Ibañez JJ
    J Clin Endocrinol Metab; 2009 Dec; 94(12):4844-50. PubMed ID: 19897681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.